螯合疗法。
Chelation therapy.
作者信息
Carven P C, Morrelli H F
出版信息
West J Med. 1975 Mar;122(3):277-8.
Abstract
This statement was prepared in response to a request made to the Clinical Pharmacology Service at the University of California, San Francisco to evaluate the potential therapeutic uses and the possible toxicities of chelation therapy. The question arose in regard to the use of ethylene tetraacetic acid (EDTA) in the treatment of atherosclerotic cardiovascular disease.
摘要
本声明是应向加利福尼亚大学旧金山分校临床药理服务部提出的一项请求而编写的，该请求旨在评估螯合疗法的潜在治疗用途和可能的毒性。关于使用乙二胺四乙酸（EDTA）治疗动脉粥样硬化性心血管疾病的问题由此产生。
相似文献
1
Chelation therapy.螯合疗法。
West J Med. 1975 Mar;122(3):277-8.
2
EDTA chelation for calcific band keratopathy.乙二胺四乙酸螯合疗法治疗钙化性带状角膜病变。
Am J Ophthalmol. 2005 Jan;139(1):216; author reply 216. doi: 10.1016/j.ajo.2004.07.060.
3
EDTA chelation for calcific band keratopathy: results and long-term follow-up.乙二胺四乙酸螯合疗法治疗钙化性带状角膜病变：结果与长期随访
Am J Ophthalmol. 2004 Jun;137(6):1056-64. doi: 10.1016/j.ajo.2004.01.036.
4
EDTA chelation therapy, without added vitamin C, decreases oxidative DNA damage and lipid peroxidation.不含额外添加维生素C的乙二胺四乙酸螯合疗法可减少氧化性DNA损伤和脂质过氧化。
Altern Med Rev. 2009 Mar;14(1):56-61.
5
Chelation therapy.螯合疗法。
N Z Med J. 1983 Feb 23;96(726):144-5.
6
EDTA chelation effects on urinary losses of cadmium, calcium, chromium, cobalt, copper, lead, magnesium, and zinc.乙二胺四乙酸螯合作用对镉、钙、铬、钴、铜、铅、镁和锌尿排泄量的影响。
Biol Trace Elem Res. 2001 Dec;83(3):207-21. doi: 10.1385/BTER:83:3:207.
7
Acute prooxidant effects of vitamin C in EDTA chelation therapy and long-term antioxidant benefits of therapy.维生素C在EDTA螯合疗法中的急性促氧化作用及该疗法的长期抗氧化益处。
Free Radic Biol Med. 2005 Jun 15;38(12):1565-70. doi: 10.1016/j.freeradbiomed.2005.02.016. Epub 2005 Mar 17.
8
Chelation therapies: a chemical and biochemical perspective.螯合疗法：化学和生物化学视角。
Curr Med Chem. 2010;17(31):3658-72. doi: 10.2174/092986710793213760.
9
Efficacy of succimer chelation for reducing brain Pb levels in a rodent model.二巯基琥珀酸螯合疗法在降低啮齿动物模型脑铅含量方面的疗效。
Environ Res. 1998 Aug;78(2):168-76. doi: 10.1006/enrs.1998.3854.
10
Pediatric fatality secondary to EDTA chelation.乙二胺四乙酸螯合疗法导致的儿科死亡
Clin Toxicol (Phila). 2008 Dec;46(10):1083-4. doi: 10.1080/15563650701261488.
引用本文的文献
1
Chelation therapy in workers with lead exposure.铅暴露工人的螯合疗法。
West J Med. 1993 Apr;158(4):372-5.
本文引用的文献
1
Toxic side effects of ethylenedia minetetraacetic acid.
J Chronic Dis. 1963 Apr;16:319-23. doi: 10.1016/0021-9681(63)90081-x.
2
Treatment of angina pectoris with disodium ethylene diamine tetraacetic acid.用乙二胺四乙酸二钠治疗心绞痛。
Am J Med Sci. 1956 Dec;232(6):654-66. doi: 10.1097/00000441-195612000-00006.
3
Nephrotoxic hazard from uncontrolled edathamil calcium-disodium therapy.
J Am Med Assoc. 1956 Mar 24;160(12):1042-6. doi: 10.1001/jama.1956.02960470038010.
4
Pathologic changes associated with the use of sodium ethylene diamine tetra-acetate in the treatment of hypercalcemia; report of two cases with autopsy findings.乙二胺四乙酸钠用于治疗高钙血症相关的病理变化；两例尸检结果报告
N Engl J Med. 1955 Mar 3;252(9):331-7. doi: 10.1056/NEJM195503032520901.
5
The in vivo dissolution of metastatic calcium; an approach to atherosclerosis.转移性钙的体内溶解；一种研究动脉粥样硬化的方法。
Am J Med Sci. 1955 Feb;229(2):142-9. doi: 10.1097/00000441-195502000-00004.
6
Treatment of lead poisoning.铅中毒的治疗。
Mod Treat. 1971 Aug;8(3):593-611.
7
Teratogenic effects of a chelating agent and their prevention by zinc.一种螯合剂的致畸作用及其锌预防作用
Science. 1971 Jul 2;173(3991):62-4. doi: 10.1126/science.173.3991.62.
8
The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood.螯合剂在儿童急慢性铅中毒治疗中的应用。
J Pediatr. 1968 Jul;73(1):1-38. doi: 10.1016/s0022-3476(68)80036-8.
Zotero 插件